- Home
- YSXT vs CALC Comparison
YSXT vs CALC Comparison
Compare YSXT & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YSXT
- CALC
- Stock Information
- Founded
- YSXT 2011
- CALC 2011
- Country
- YSXT China
- CALC United States
- Employees
- YSXT N/A
- CALC N/A
- Industry
- YSXT Automotive Aftermarket
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- YSXT Consumer Discretionary
- CALC Health Care
- Exchange
- YSXT Nasdaq
- CALC Nasdaq
- Market Cap
- YSXT 58.6M
- CALC 48.1M
- IPO Year
- YSXT 2024
- CALC N/A
- Fundamental
- Price
- YSXT $2.61
- CALC $3.17
- Analyst Decision
- YSXT
- CALC Strong Buy
- Analyst Count
- YSXT 0
- CALC 2
- Target Price
- YSXT N/A
- CALC $14.50
- AVG Volume (30 Days)
- YSXT 548.1K
- CALC 63.4K
- Earning Date
- YSXT 07-31-2025
- CALC 11-12-2025
- Dividend Yield
- YSXT N/A
- CALC N/A
- EPS Growth
- YSXT N/A
- CALC N/A
- EPS
- YSXT 0.18
- CALC N/A
- Revenue
- YSXT $71,452,736.00
- CALC N/A
- Revenue This Year
- YSXT N/A
- CALC N/A
- Revenue Next Year
- YSXT N/A
- CALC N/A
- P/E Ratio
- YSXT $14.54
- CALC N/A
- Revenue Growth
- YSXT 22.04
- CALC N/A
- 52 Week Low
- YSXT $1.68
- CALC $1.42
- 52 Week High
- YSXT $9.96
- CALC $5.65
- Technical
- Relative Strength Index (RSI)
- YSXT 47.82
- CALC 53.86
- Support Level
- YSXT $2.32
- CALC $3.00
- Resistance Level
- YSXT $2.55
- CALC $3.73
- Average True Range (ATR)
- YSXT 0.23
- CALC 0.31
- MACD
- YSXT 0.10
- CALC 0.04
- Stochastic Oscillator
- YSXT 70.78
- CALC 46.67
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.